Should You Be Worried About OHSS?

When natural attempts at pregnancy are unsuccessful, some couples turn to in vitro fertilization (IVF) to conceive. IVF is a relatively safe procedure overall, but in rare cases, complications can occur. Ovarian hyperstimulation syndrome (OHSS) is a possible complication that can occur in women taking injectable medications to stimulate egg development in the ovaries. Fertility drugs are designed to encourage the development of multiple eggs, but in some cases, the response becomes exaggerated. Most cases of OHSS are mild and resolve independently, but moderate-to-severe cases require closer monitoring. Women undergoing fertility treatment should understand possible symptoms and treatment options should OHSS develop.

mid-iowa-fertility-IVF-Complications-How-To-Treat-Ovarian-Hyperstimulation-Syndrome

Causes of OHSS

Affecting approximately 1-10% of women undergoing IVF, OHSS develops when the ovaries produce an excessive number of follicles in response to fertility medications. The ovaries can become swollen and painful, and fluid leaks into the abdomen. Certain patients are at higher risk of OHSS, including women with polycystic ovary syndrome (PCOS) or high ovarian reserve. Younger age and prior history of ovarian hyperstimulation also increase susceptibility.

Possible symptoms to watch for

Although OHSS isn’t super common, any woman undergoing IVF should know the possible symptoms. Mild cases often include bloating, abdominal discomfort, and slight weight gain. Moderate symptoms may involve nausea, vomiting, and increased abdominal swelling. Severe cases can present with rapid weight gain, shortness of breath, and decreased urine output. Early recognition of symptoms allows for prompt evaluation and appropriate management.

Treatment options

If OHSS develops, treatment will depend on the severity of symptoms and overall clinical presentation. Mild cases are typically managed with rest, hydration, and close monitoring at home. Patients are often advised to track weight and fluid intake. Moderate cases may require office visits, laboratory testing, and ultrasound evaluation to monitor fluid levels. Severe cases sometimes require hospitalization for intravenous (IV) fluids, drainage of excess fluid, and careful observation. In cases of moderate or severe OHSS, the fertility doctor will likely recommend postponing the embryo transfer until the condition has resolved.

Prevention strategies during IVF

When a woman undergoes fertility treatment, efforts are made to prevent OHSS. Physicians may adjust medication doses or use alternative trigger injections to reduce risk. In some cases, embryos are frozen, and transfer is delayed, allowing hormone levels to stabilize. Frequent monitoring with bloodwork and ultrasound helps guide safe medication adjustments. Individualized treatment protocols can significantly reduce the likelihood of severe complications.

A safer path through treatment

Ovarian hyperstimulation syndrome remains a manageable IVF complication with proper awareness and medical care. Most cases are mild and resolve without long-term effects. Early communication with a fertility team ensures symptoms are addressed promptly and appropriately. Advances in IVF protocols continue to improve safety and reduce risk.